Malignant Neoplasm of Stomach Completed Phase 3 Trials for Capecitabine (DB01101)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00323830Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaTreatment
NCT00678535Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric CancerTreatment
NCT00718354Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CTSupportive Care
NCT00887822A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Cisplatin as First-Line Therapy for Advanced Gastric CancerTreatment
NCT01041404ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric CancerTreatment
NCT02560974A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric CancerTreatment
NCT02563054A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric CancerTreatment